Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells

被引:0
|
作者
Masahiro Murakami
Shogo Kobayashi
Shigeru Marubashi
Yoshito Tomimaru
Takehiro Noda
Hiroshi Wada
Hidetoshi Eguchi
Yutaka Takeda
Masahiro Tanemura
Koji Umeshita
Yuichiro Doki
Masaki Mori
Hiroaki Nagano
机构
[1] Osaka University,Department of Surgery, Graduate School of Medicine
来源
关键词
Vascular Endothelial Growth Factor; Sorafenib; HuH7 Cell; Vascular Endothelial Growth Factor Signaling; Portal Vein Tumor Thrombus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:589 / 596
页数:7
相关论文
共 50 条
  • [41] Combination of calcineurin B subunit (CnB) and 5-fluorouracil reverses 5-fluorouracil-induced immunosuppressive effect and enhances the antitumor activity in hepatocellular carcinoma
    Zhang, Wenlong
    Zhong, Youxiu
    Cui, Hongfei
    Wang, Liya
    Yang, Rui
    Su, Zhenyi
    Xiang, Benqiong
    Wei, Qun
    ONCOLOGY LETTERS, 2017, 14 (05) : 6135 - 6142
  • [42] Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: An animal study
    Schoenberger, J
    Grimm, D
    Kossmehl, P
    Infanger, M
    Kurth, E
    Eilles, C
    ENDOCRINOLOGY, 2004, 145 (03) : 1031 - 1038
  • [43] Metastatic jejunal VIPoma:: Beneficial effect of combination therapy with interferon-α and 5-fluorouracil
    Cellier, C
    Yaghi, C
    Cuillerier, E
    Siauve, N
    Berger, A
    Carnot, F
    Haddad, C
    Barbier, JP
    Landi, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (01): : 289 - 293
  • [44] The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-α
    Oie, Shinji
    Ono, Mayumi
    Yang, Hirohisa
    Maruyama, Yuichiro
    Terada, Tadafumi
    Yamada, Yuji
    Ueno, Takato
    Kojiro, Masamichi
    Hirano, Kazuyuki
    Kuwano, Michihiko
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (06) : 1469 - 1478
  • [45] Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-α in a hemodialysis patient
    Katamura, Yoshio
    Aikata, Hiroshi
    Kimura, Yuki
    Azakami, Takahiro
    Kawaoka, Tomokazu
    Takaki, Shintaro
    Waki, Koji
    Hiramatsu, Akira
    Kawakami, Yoshiiku
    Takahashi, Shoichi
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2009, 39 (04) : 415 - 420
  • [46] CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells
    Takagi, Koichi
    Sowa, Yoshihiro
    Cevik, Ozgur Muhammer
    Nakanishi, Ryoko
    Sakai, Toshiyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (05) : 1105 - 1110
  • [47] Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells
    Rossi, Ursula A.
    Finocchiaro, Liliana M. E.
    Glikin, Gerardo C.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (05) : 754 - 761
  • [48] Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-α/5-fluorouracil against hepatocellular carcinoma
    Yamamoto, T
    Nagano, H
    Sakon, M
    Wada, H
    Eguchi, H
    Kondo, M
    Damdinsuren, B
    Ota, H
    Nakamura, M
    Wada, H
    Marubashi, S
    Miyamoto, A
    Dono, K
    Umeshita, K
    Nakamori, S
    Yagita, H
    Monden, M
    CLINICAL CANCER RESEARCH, 2004, 10 (23) : 7884 - 7895
  • [49] A pilot trial of combination cisplatin, 5-fluorouracil and interferon-α in the treatment of advanced Esophageal carcinoma
    Bazarbashi, S
    Rahal, M
    Raja, MA
    El Weshi, A
    Pai, C
    Ezzat, A
    Ajarim, D
    Memon, M
    Al Fadda, M
    CHEMOTHERAPY, 2002, 48 (04) : 211 - 216
  • [50] Immunochemotherapy with 5-Fluorouracil and Interferon-α Enhances Innate and Adoptive Immune Responses Against Pancreatic Cancer
    Khallouf, H.
    Serba, S.
    Maerten, A.
    Jaeger, D.
    Schmidt, J.
    PANCREAS, 2010, 39 (08) : 1327 - 1327